Healthcare Professionals Home
What Is Restless Legs Syndrome?
Impact of Restless Legs Syndrome
Diagnosing Restless Legs Syndrome
Etiology
Restless Legs Syndrome Resources
Restless Legs Syndrome for Patients
  The REST (RLS Epidemiology, Symptoms and Treatment) Study in Primary Care, funded by GlaxoSmithKline, included all patients (n = 23,052) visiting 182 primary care doctors in the United States and Western Europe over a 2-week period. Of the 551 patients self-reported as "RLS sufferers" by the validated study criteria, selected survey findings included4,8:
  • 68.6% reported taking more than 30 minutes to get to sleep
  • 60.1% reported waking 3 or more times per night
  • 60.8% reported that they lacked energy when experiencing RLS symptoms
  • 60.1% found it difficult to sit or relax
  • 57.2% stated that their daily activities were disturbed
 
CONTACT US SITE MAP E-MAIL A COLLEAGUE
This site is intended for US healthcare professionals only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Contact Us